Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
209.3 USD | +0.42% | -2.96% | -11.95% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.95% | 10.74B | |
+50.63% | 54.63B | |
-4.75% | 39.92B | |
+37.52% | 38.82B | |
+15.75% | 26.86B | |
-12.56% | 26.22B | |
-21.64% | 18.78B | |
+25.51% | 12.21B | |
+1.95% | 12.16B | |
+26.99% | 11.94B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- JPMorgan Adjusts Price Target on Charles River Laboratories International to $270 From $280